Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sosei Group, an international biopharmaceutical company, and its wholly owned subsidiary Activus Pharma have signed a joint development pact with Toa Pharmaceuticals and its subsidiary Nitto Medic.
Subscribe to our email newsletter
As per the terms of the agreement, all the companies will jointly organize research and development to evaluate the feasibility of developing various ophthalmic solutions applying Activus Pure Nano-particle Technology (APNT).
The companies said that following the identification of the product, they will sign a separate agreement for the commercialization of the product.